Literature DB >> 16632345

Stem cell plasticity and tumour formation.

Malcolm R Alison1, Matthew J Lovell, Natalie C Direkze, Nicholas A Wright, Richard Poulsom.   

Abstract

Stem cell plasticity refers to the ability of certain stem cells to switch lineage determination and generate unexpected cell types. This review applies largely to bone marrow cells (BMCs), which appear to contribute positively to the regeneration of several damaged non-haematopoietic tissues. This beneficial effect on regeneration may be a direct result of BMCs giving rise to organ parenchymal cells. Alternatively, it could be due to BMCs fusing with existing parenchymal cells, or providing paracrine growth factor support, or contributing to neovascularisation. In the context of oncology, BMC derivation of the tumour stroma and vasculature has profound biological and therapeutic implications, and there are several examples of carcinomas seemingly being derived from BMCs.

Entities:  

Mesh:

Year:  2006        PMID: 16632345     DOI: 10.1016/j.ejca.2006.01.034

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  4 in total

1.  Histochemical localization of caldesmon isoforms in colon adenocarcinoma and lymph node metastases.

Authors:  Christoph Köhler
Journal:  Virchows Arch       Date:  2011-05-29       Impact factor: 4.064

2.  Recruitment and activation of pancreatic stellate cells from the bone marrow in pancreatic cancer: a model of tumor-host interaction.

Authors:  Christopher J Scarlett; Emily K Colvin; Mark Pinese; David K Chang; Adrienne L Morey; Elizabeth A Musgrove; Marina Pajic; Minoti Apte; Susan M Henshall; Robert L Sutherland; James G Kench; Andrew V Biankin
Journal:  PLoS One       Date:  2011-10-14       Impact factor: 3.240

3.  Contribution of bone marrow derived cells to the pancreatic tumor microenvironment.

Authors:  Christopher J Scarlett
Journal:  Front Physiol       Date:  2013-03-26       Impact factor: 4.566

4.  Mesenchymal stem cell transplantation improves chronic colitis-associated complications through inhibiting the activity of toll-like receptor-4 in mice.

Authors:  Guo Chao Niu; Lei Liu; Libo Zheng; Hong Zhang; David Q Shih; Xiaolan Zhang
Journal:  BMC Gastroenterol       Date:  2018-08-13       Impact factor: 3.067

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.